Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 9, 2021
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
[ Wed, Jun 09th 2021
] - WOPRAI
Robert Koort Upgraded (CC) to Strong Buy and Increased Target to $47 on, Jun 9th, 2021
Robert Koort of Goldman Sachs, Upgraded "The Chemours Company" (CC) to Strong Buy and Increased Target from $35 to $47 on, Jun 9th, 2021.
Robert has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Monday, May 10th, 2021
These are the ratings of the 2 analyists that currently disagree with Robert
- Matthew DeYoe of "B of A Securities" Initiated at Strong Buy and Held Target at $42 on, Thursday, May 20th, 2021
- David Coleman of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $40 on, Thursday, May 6th, 2021
